Hot Features
Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Canada’s health minister calls for action to fight the worrisome tide of opioid addiction and opioid-related deaths in Canada. Delivra is a Canadian-born pain relief solution that is taking...
DENVER, Oct. 1 /PRNewswire-FirstCall/ -- DaVita Inc. (NYSE:DVA), a leading provider of kidney care services for those diagnosed with chronic kidney disease (CKD), today announced the company has...
DENVER, Sept. 15 /PRNewswire-FirstCall/ -- DaVita Inc. (NYSE:DVA), a leading provider of kidney care services for those diagnosed with chronic kidney disease (CKD), has been recognized in the...
Thiry Ranks among Most-Influential Health Care Leaders for Second Consecutive Year DENVER, Aug. 31 /PRNewswire-FirstCall/ -- DaVita Inc. (NYSE:DVA), a leading provider of kidney care services for...
DaVita dialysis facilities recognized for patient quality improvement DENVER, Aug. 19 /PRNewswire-FirstCall/ -- DaVita Inc. (NYSE:DVA), a leading provider of kidney care services for those...
EL SEGUNDO, Calif., Aug. 4 /PRNewswire-FirstCall/ -- DaVita Inc. (NYSE: DVA) today announced results for the quarter ended June 30, 2009. Net income attributable to DaVita Inc. for the three and...
Awards Granted to Less Than Six Percent of Clinics Overseen by End Stage Renal Disease Network DENVER, July 24 /PRNewswire-FirstCall/ -- DaVita Inc. (NYSE:DVA), a leading provider of kidney care...
Bridge of Life - DaVita Medical Missions Partners with Government to Offer Renal Awareness Camps TACOMA, Wash., July 10 /PRNewswire/ -- Bridge of Life - DaVita Medical Missions, a 501(c)(3...
DaVita Offers Nearly 600 Kidney-Friendly Recipes to Meet Kidney Care Needs for Dads with CKD DENVER, June 20 /PRNewswire-FirstCall/ -- DaVita Inc. (NYSE:DVA), a leading provider of kidney care...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
